Clinical trial
Extracorporeal Carbon Dioxide Removal for Acute Respiratory Distress Syndrome
NCT00000572 · Intermountain Health Care, Inc., Other · Completed
Key facts
| NCT number | NCT00000572 |
|---|---|
| Title | Extracorporeal Carbon Dioxide Removal for Acute Respiratory Distress Syndrome |
| Official title | Extracorporeal Carbon Dioxide Removal for Acute Respiratory Distress Syndrome |
| Lead sponsor | Intermountain Health Care, Inc., Other |
| Collaborators | National Heart, Lung, and Blood Institute (NHLBI) NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Acute Respiratory Distress Syndrome, Lung Diseases |
| Intervention type | Procedure |
| Interventions | positive-pressure ventilation, extracorporeal membrane oxygenation (CO2 removal) |
| Enrollment | 40 |
| Start date | Jun 1, 1987 |
| Primary completion | Apr 1, 1991 |
| Completion | Jan 1, 1993 |
| First posted | Oct 28, 1999 |
| Last update posted | Mar 6, 2018 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: